Data as of Aug 01
| -0.34 / -1.79%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 18.00, with a high estimate of 21.00 and a low estimate of 15.00. The median estimate represents a -3.74% decrease from the last price of 18.70.
The current consensus among 2 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.